New ultrasound biopsy could replace risky lung surgery for scarred lungs

NCT ID NCT07305220

Not yet recruiting Diagnosis Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an ultrasound-guided needle biopsy is a safe way to diagnose interstitial lung disease (ILD), a group of conditions that scar the lungs. Fifteen adults who need a tissue sample will first get the ultrasound-guided biopsy under local anesthesia, then have the standard surgical biopsy. Researchers will track serious complications like collapsed lung or bleeding to see if the less invasive method is safe enough to use routinely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ultrasound-guided lung biopsy
What this could lead to: If this procedure proves safe, it could offer a less risky, outpatient alternative to surgical lung biopsy for diagnosing interstitial lung disease.
What could go wrong: This is a very small, early feasibility study with only 15 people. The procedure may still cause complications like collapsed lung or bleeding, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE (ILD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERSTITIAL LUNG DISEASE (ILD)

Contacts and locations

Locations

Pneumology department

Tours, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.